ID   DRD4_RAT                Reviewed;         387 AA.
AC   P30729; Q62610;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   02-OCT-2024, entry version 165.
DE   RecName: Full=D(4) dopamine receptor;
DE   AltName: Full=D(2C) dopamine receptor;
DE   AltName: Full=Dopamine D4 receptor;
GN   Name=Drd4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1554689;
RA   O'Malley K.L., Harmon S., Tang L., Todd R.D.;
RT   "The rat dopamine D4 receptor: sequence, gene structure, and demonstration
RT   of expression in the cardiovascular system.";
RL   New Biol. 4:137-146(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=8078498;
RA   Asghari V., Schoots O., van Kats S., Ohara K., Jovanovic V., Guan H.-C.,
RA   Bunzow J.R., Petronis A., Van Tol H.H.M.;
RT   "Dopamine D4 receptor repeat: analysis of different native and mutant forms
RT   of the human and rat genes.";
RL   Mol. Pharmacol. 46:364-373(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10832611; DOI=10.1007/s002100000236;
RA   Gazi L., Schoeffter P., Nunn C., Croskery K., Hoyer D., Feuerbach D.;
RT   "Cloning, expression, functional coupling and pharmacological
RT   characterization of the rat dopamine D4 receptor.";
RL   Naunyn Schmiedebergs Arch. Pharmacol. 361:555-564(2000).
RN   [5]
RP   INTERACTION WITH CLIC6.
RX   PubMed=14499480; DOI=10.1016/s0169-328x(03)00283-3;
RA   Griffon N., Jeanneteau F., Prieur F., Diaz J., Sokoloff P.;
RT   "CLIC6, a member of the intracellular chloride channel family, interacts
RT   with dopamine D(2)-like receptors.";
RL   Brain Res. Mol. Brain Res. 117:47-57(2003).
CC   -!- FUNCTION: Dopamine receptor responsible for neuronal signaling in the
CC       mesolimbic system of the brain, an area of the brain that regulates
CC       emotion and complex behavior. Activated by dopamine, but also by
CC       epinephrine and norepinephrine, and by numerous synthetic agonists and
CC       drugs (By similarity). Agonist binding triggers signaling via G
CC       proteins that inhibit adenylyl cyclase (PubMed:10832611). Modulates the
CC       circadian rhythm of contrast sensitivity by regulating the rhythmic
CC       expression of NPAS2 in the retinal ganglion cells (By similarity).
CC       {ECO:0000250|UniProtKB:P21917, ECO:0000250|UniProtKB:P51436,
CC       ECO:0000269|PubMed:10832611}.
CC   -!- SUBUNIT: Forms homo- and heterooligomers with DRD2. D4.7 allele
CC       exhibits higher affinity for homodimers compared to DRD2 heterodimers,
CC       while alleles D42. and 4.4 have similar affinities for both. The
CC       interaction with DRD2 may modulate agonist-induced downstream signaling
CC       (By similarity). Interacts with CLIC6 (PubMed:14499480). Interacts with
CC       GPRASP1. May interact with ADORA2A. Interacts with KLHL12 (By
CC       similarity). {ECO:0000250|UniProtKB:P21917,
CC       ECO:0000269|PubMed:14499480}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10832611};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P21917}.
CC   -!- TISSUE SPECIFICITY: Central nervous system: hypothalamus, thalamus,
CC       olfactory bulb, and frontal cortex.
CC   -!- PTM: Polyubiquitinated by the BCR(KLHL12) E3 ubiquitin ligase complex:
CC       polyubiquitination does not lead to degradation of DRD4 protein.
CC       {ECO:0000250|UniProtKB:P21917}.
CC   -!- PTM: Palmitoylated. Palmitoylation of the C-terminal Cys is important
CC       for normal expression at the cell membrane.
CC       {ECO:0000250|UniProtKB:P21917}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M84009; AAA96716.1; -; mRNA.
DR   EMBL; U03551; AAA18588.1; -; Genomic_DNA.
DR   EMBL; AC118351; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; P30729; -.
DR   SMR; P30729; -.
DR   DIP; DIP-59866N; -.
DR   IntAct; P30729; 2.
DR   STRING; 10116.ENSRNOP00000024137; -.
DR   BindingDB; P30729; -.
DR   ChEMBL; CHEMBL3361; -.
DR   DrugCentral; P30729; -.
DR   GuidetoPHARMACOLOGY; 217; -.
DR   GlyCosmos; P30729; 1 site, No reported glycans.
DR   GlyGen; P30729; 1 site.
DR   PhosphoSitePlus; P30729; -.
DR   PaxDb; 10116-ENSRNOP00000024137; -.
DR   AGR; RGD:2522; -.
DR   RGD; 2522; Drd4.
DR   eggNOG; KOG3656; Eukaryota.
DR   InParanoid; P30729; -.
DR   PhylomeDB; P30729; -.
DR   Reactome; R-RNO-390651; Dopamine receptors.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:P30729; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0044292; C:dendrite terminus; IDA:RGD.
DR   GO; GO:1901588; C:dendritic microtubule; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0035240; F:dopamine binding; IDA:RGD.
DR   GO; GO:0004952; F:dopamine neurotransmitter receptor activity; ISO:RGD.
DR   GO; GO:0001591; F:dopamine neurotransmitter receptor activity, coupled via Gi/Go; IDA:RGD.
DR   GO; GO:0051379; F:epinephrine binding; ISO:RGD.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IBA:GO_Central.
DR   GO; GO:1901363; F:heterocyclic compound binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0051380; F:norepinephrine binding; ISO:RGD.
DR   GO; GO:0051378; F:serotonin binding; IBA:GO_Central.
DR   GO; GO:0017124; F:SH3 domain binding; ISO:RGD.
DR   GO; GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007198; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0050482; P:arachidonic acid secretion; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; IMP:RGD.
DR   GO; GO:0001662; P:behavioral fear response; IMP:RGD.
DR   GO; GO:0048148; P:behavioral response to cocaine; ISO:RGD.
DR   GO; GO:0099004; P:calmodulin dependent kinase signaling pathway; IDA:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0042596; P:fear response; ISO:RGD.
DR   GO; GO:0007212; P:G protein-coupled dopamine receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISO:RGD.
DR   GO; GO:0098828; P:modulation of inhibitory postsynaptic potential; IDA:RGD.
DR   GO; GO:0050709; P:negative regulation of protein secretion; ISO:RGD.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IDA:RGD.
DR   GO; GO:0032229; P:negative regulation of synaptic transmission, GABAergic; IDA:RGD.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; IDA:RGD.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; IDA:RGD.
DR   GO; GO:0008355; P:olfactory learning; IMP:RGD.
DR   GO; GO:0009648; P:photoperiodism; IEP:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0060406; P:positive regulation of penile erection; IDA:RGD.
DR   GO; GO:0060134; P:prepulse inhibition; IMP:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; IMP:RGD.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0042053; P:regulation of dopamine metabolic process; ISO:RGD.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; IMP:RGD.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IDA:SynGO.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; ISO:RGD.
DR   GO; GO:0010738; P:regulation of protein kinase A signaling; IDA:RGD.
DR   GO; GO:0001975; P:response to amphetamine; ISO:RGD.
DR   GO; GO:0071871; P:response to epinephrine; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0034776; P:response to histamine; ISO:RGD.
DR   GO; GO:0009416; P:response to light stimulus; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0097066; P:response to thyroid hormone; IEP:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEP:RGD.
DR   GO; GO:0007614; P:short-term memory; IMP:RGD.
DR   GO; GO:0001963; P:synaptic transmission, dopaminergic; IMP:RGD.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR002185; Dopamine_D4_rcpt.
DR   InterPro; IPR000929; Dopamine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24248:SF143; D(4) DOPAMINE RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00569; DOPAMINED4R.
DR   PRINTS; PR00242; DOPAMINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Biological rhythms; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane;
KW   Metal-binding; Palmitate; Receptor; Reference proteome; Sodium; Transducer;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..387
FT                   /note="D(4) dopamine receptor"
FT                   /id="PRO_0000069403"
FT   TOPO_DOM        1..34
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TRANSMEM        35..57
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TOPO_DOM        58..67
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TRANSMEM        68..90
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TOPO_DOM        91..106
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TRANSMEM        107..128
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TOPO_DOM        129..146
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TRANSMEM        147..170
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TOPO_DOM        171..186
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TRANSMEM        187..208
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TOPO_DOM        209..314
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TRANSMEM        315..337
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TOPO_DOM        338..346
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TRANSMEM        347..369
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   TOPO_DOM        370..387
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   REGION          224..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        232..260
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        261..278
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         77
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   BINDING         119
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   LIPID           387
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   CARBOHYD        3
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        105..180
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        340..343
FT                   /evidence="ECO:0000250|UniProtKB:P21917"
FT   CONFLICT        93..94
FT                   /note="Missing (in Ref. 1; AAA96716)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   387 AA;  41294 MW;  1E0A5D74524F5050 CRC64;
     MGNSSATGDG GLLAGRGPES LGTGTGLGGA GAAALVGGVL LIGMVLAGNS LVCVSVASER
     ILQTPTNYFI VSLAAADLLL AVLVLPLFVY SEVQGGVWLL SPRLCDTLMA MDVMLCTASI
     FNLCAISVDR FVAVTVPLRY NQQGQCQLLL IAATWLLSAA VAAPVVCGLN DVPGRDPTVC
     CLEDRDYVVY SSICSFFLPC PLMLLLYWAT FRGLRRWEAA RHTKLHSRAP RRPSGPGPPV
     SDPTQGPLFS DCPPPSPSLR TSPTVSSRPE SDLSQSPCSP GCLLPDAALA QPPAPSSRRK
     RGAKITGRER KAMRVLPVVV GAFLMCWTPF FVVHITRALC PACFVSPRLV SAVTWLGYVN
     SALNPIIYTI FNAEFRSVFR KTLRLRC
//
